7.17
                                            Schlusskurs vom Vortag:
              $7.34
            Offen:
              $7.45
            24-Stunden-Volumen:
                46,151
            Relative Volume:
              0.62
            Marktkapitalisierung:
                $32.71M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-14.56M
            KGV:
              -0.4263
            EPS:
                -16.82
            Netto-Cashflow:
                $-12.46M
            1W Leistung:
              -4.40%
            1M Leistung:
              -4.40%
            6M Leistung:
                +24.37%
            1J Leistung:
              +59.87%
            Tenax Therapeutics Inc Stock (TENX) Company Profile
Firmenname
                  
                      Tenax Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      919-855-2100
                    
                Adresse
                  
                      101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
                    
                Vergleichen Sie TENX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                TENX
                            
                             
                        Tenax Therapeutics Inc 
                           | 
                    7.17 | 33.49M | 0 | -14.56M | -12.46M | -16.82 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-09-08 | Eingeleitet | Piper Sandler | Overweight | 
| 2024-10-24 | Eingeleitet | Leerink Partners | Outperform | 
| 2024-10-14 | Eingeleitet | Guggenheim | Buy | 
| 2024-09-30 | Eingeleitet | William Blair | Outperform | 
| 2017-05-18 | Hochstufung | Ladenburg Thalmann | Neutral → Buy | 
| 2014-12-16 | Eingeleitet | MLV & Co | Buy | 
| 2014-11-18 | Eingeleitet | WallachBeth | Buy | 
                    Alle ansehen
                    
                  
                Tenax Therapeutics Inc Aktie (TENX) Neueste Nachrichten
Forecasting Tenax Therapeutics Inc. price range with options dataWeekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
Should you hold or exit Tenax Therapeutics Inc. now2025 Breakouts & Breakdowns & Consistent Profit Alerts - newser.com
Understanding Tenax Therapeutics Inc.’s price movementWeekly Trade Summary & Consistent Profit Focused Trading Strategies - newser.com
Why Tenax Therapeutics Inc. stock is a must watch in 2025Sell Signal & Community Consensus Trade Alerts - newser.com
How sentiment analysis helps forecast Tenax Therapeutics Inc.Portfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - Investing News Network
Top chart patterns to watch in Tenax Therapeutics Inc.CEO Change & High Win Rate Trade Tips - newser.com
Why retail investors favor Tenax Therapeutics Inc. stockMarket Movement Recap & Smart Investment Allocation Tips - newser.com
How Tenax Therapeutics Inc. stock compares to growth peersEarnings Beat & High Accuracy Swing Trade Signals - newser.com
Combining machine learning predictions for Tenax Therapeutics Inc.Fed Meeting & Real-Time Sentiment Analysis - newser.com
Is now a turning point for Tenax Therapeutics Inc.Earnings Recap Report & Technical Confirmation Trade Alerts - newser.com
Can trapped investors hope for a rebound in Tenax Therapeutics Inc.2025 Valuation Update & Long-Term Growth Stock Strategies - newser.com
Historical volatility pattern of Tenax Therapeutics Inc. visualizedJuly 2025 EndofMonth & Reliable Volume Spike Alerts - newser.com
Will Tenax Therapeutics Inc. stock recover after recent dropTrade Risk Assessment & High Win Rate Trade Alerts - newser.com
Will Tenax Therapeutics Inc. stock benefit from infrastructure spendingJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
Analyzing drawdowns of Tenax Therapeutics Inc. with statistical toolsJuly 2025 PreEarnings & Free Fast Entry Momentum Trade Alerts - newser.com
Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):